Association between Gene Expression Profiles and Clinical Outcome of Pemetrexed-Based Treatment in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: Exploratory Results from a Phase II Study

• Dean A. Fennell ,

  * E-mail: df132@leicester.ac.uk

  Affiliation Leicester University Hospital, Leicester, United Kingdom

  ⨯
• Scott P. Myrand,

  Affiliation Eli Lilly and Company, Indianapolis, IN, United States of America

  ⨯
• Tuan S. Nguyen,

  Affiliation Eli Lilly and Company, Indianapolis, IN, United States of America

  ⨯
• David Ferry,

  Current address: Eli Lilly and Company, Erl Wood Manor, Windlesham, United Kingdom

  Affiliation New Cross Hospital, Wolverhampton, United Kingdom

  ⨯
• Keith M. Kerr,

  Affiliation Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, United Kingdom

  ⨯
• Perry Maxwell,

  Affiliation Queens University, Belfast, United Kingdom

  ⨯
• Stephen D. Moore,

  Affiliation Almac Diagnostics, Craigavon, United Kingdom

  ⨯
• Carla Visseren-Grul,

  Affiliation Eli Lilly and Company, Houten, Netherlands

  ⨯
• Mayukh Das,

  Affiliation Eli Lilly and Company, Basingstoke, United Kingdom

  ⨯
• Marianne C. Nicolson

  Affiliation Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, United Kingdom

  ⨯